WINNIPEG, Dec. 5, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Kelly McNeill, IMRIS Chief Financial Officer will present at the Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference on December 6, 2011 at 3:00 pm Pacific Time. An audio webcast of Mr. McNeill's presentation will be available at www.imris.com.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.
SOURCE IMRIS Inc.